In Pharmacoepidemiology and drug safety
PURPOSE : Signal detection is a crucial step in the discovery of post-marketing adverse drug reactions. There is a growing interest in using routinely collected data to complement established spontaneous report analyses. This work aims to systematically review the methods for drug safety signal detection using routinely collected healthcare data and their performance, both in general and for specific types of drugs and outcomes.
METHODS : We conducted a systematic review following the PRISMA guidelines, and registered a protocol in PROSPERO. MEDLINE, EMBASE, PubMed, Web of Science, Scopus and the Cochrane Library were searched until 13th July 2021.
RESULTS : The review included 101 articles, among which there were 39 methodological works, 25 performance assessment papers and 24 observational studies. Methods included adaptations from those used with spontaneous reports, traditional epidemiological designs, methods specific to signal detection with real-world data. More recently, implementations of machine learning have been studied in the literature. 25 studies evaluated method performances, 16 of them using the area under the curve (AUC) for a range of positive and negative controls as their main measure. Despite the likelihood that performance measurement could vary by drug-event pair, only 10 studies reported performance stratified by drugs and outcomes, in a heterogeneous manner. The replicability of the performance assessment results was limited due to lack of transparency in reporting and the lack of a gold standard reference set.
CONCLUSIONS : A variety of methods have been described in the literature for signal detection with routinely collected data. No method showed superior performance in all papers and across all drugs and outcomes, performance assessment and reporting were heterogeneous. However, there is limited evidence that self-controlled designs, high dimensional propensity scores and machine learning can achieve higher performances than other methods. This article is protected by copyright. All rights reserved.
Coste Astrid, Wong Angel, Bokern Marleen, Bate Andrew, Douglas Ian J
2022-Oct-11
drug safety surveillance, pharmacoepidemiology, pharmacovigilance, real world data, signal detection, systematic review
